• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Is Healthcare Services Group (HCSG) Still Reasonable After A 103% Run?

    Simply Wall St·09/16/2026 23:27:02
    Listen to the news

    Healthcare Services Group has delivered a striking run over the past few years, which puts a spotlight on what investors are really paying for today. The key issue is whether the current share price lines up with the cash flows the business is expected to generate.

    • The stock has gained about 103.2% over the past 3 years, so a lot now rests on whether that move is matched by the strength and durability of its cash flows.
    • The company relies on long term service contracts with healthcare facilities, which can support steady cash generation but also means small shifts in pricing or client retention may have an outsized impact on future cash inflows.
    • What if you looked at Healthcare Services Group through its earnings instead? See why Healthcare Services Group's 12.2x P/E tells a different valuation story.

    The issue now is whether Healthcare Services Group's current market value is supported by the cash flows implied in its intrinsic value estimate.

    If you are comparing Healthcare Services Group with other opportunities that also depend on cash generation, it may be useful to look at companies identified in the 33 high quality undervalued stocks.

    Is Healthcare Services Group Still Cheap on Cash Flow?

    The Discounted Cash Flow (DCF) model here focuses on the cash Healthcare Services Group can return to shareholders over time. Latest twelve-month free cash flow sits around $147.8 million, which gives the valuation a foundation in actual cash generation rather than accounting earnings.

    The projections used in the DCF assume growing free cash flow, with analyst and model estimates clustering in the low $90 million range by 2027 and 2028 before stepping up gradually after that. That implies the business is treated as a relatively mature, steady cash generator rather than a high-growth story, and the cash flow curve is smoothed rather than aggressively ramped. Under those assumptions, the DCF output points to an intrinsic value that is substantially above the current share price of $21.89, which means the market is not fully reflecting the cash flows implied by this model. Find out what Healthcare Services Group could be worth using our Discounted Cash Flow (DCF) estimate.

    The Healthcare Services Group Narrative: What Would Justify Today's Price?

    Narratives for Healthcare Services Group pick up where the DCF puzzle leaves off and explain what path for growth, margins and earnings would need to occur for the stock to be worth materially more or less than today’s price on Simply Wall St’s Community page. Instead of a single output from one ratio or model, they describe the future that figure relies on so you can monitor over time whether reality is tracking that storyline.

    One of the top community narratives on Healthcare Services Group: 16% undervalued

    "A $50 million accelerated share buyback, supported by a strong balance sheet and rising cash flow from operations, creates share accretion and may catalyze stronger EPS growth..."

    Discover why this Narrative puts Healthcare Services Group at 16% undervalued.

    One more Healthcare Services Group check that belongs next to the cash flow math

    The numbers only tell part of the story, because the people steering Healthcare Services Group and the way their pay is structured can strongly influence how those cash flows are pursued and protected. See who runs Healthcare Services Group and how they are paid.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.